patients with long-term type 1 diabetes mellitus under intensive insulin treatment do not have echocardiographic, biochemical, or morphological signs of diabetic cardiomyopathy. However, as the authors admit, this is directly opposed to several previous studies which clearly show the presence of myocardial diastolic dysfunction in patients with type 1 diabetes, when compared with control subjects.
2 -4 Importantly, like Konduracka et al.,
these studies excluded patients with coronary artery disease and hypertension. These co-morbidities may themselves result in diastolic impairment, thus precluding any firm conclusions regarding the specific effect of diabetes on the human myocardium. We assert that the authors' explanation for the absence of diastolic abnormalities in their diabetic cohort is unconvincing. They speculate that myocardial overload and increased peripheral resistance after the administration of exogenous insulin may be responsible for the diastolic abnormalities seen in previous studies. However, the diabetic population studied by Konduracka et 
